Tags: healthcareRemove, pharmaceuticalsRemove

United Labs' renminbi-denominated convertible bond comes at attractive terms, but still falls below par.
By Anette Jönsson | 8 November 2011
China's second-biggest drug distributor prices its H-share offering below the mid-point, but at a modest 2.4% discount versus its A-shares.
By Anette Jönsson | 16 May 2011
The Chinese pharmaceutical distributor prices at the top to raise $1.13 billion after attracting $110 billion worth of orders. Separately, Digital China raises $49 million from ...
By Anette Jönsson | 17 September 2009
The Chinese distributor of pharmaceutical products will be the first company to take orders for a Hong Kong listing after the summer and has set the price range at HK12.25 to ...
By Anette Jönsson | 4 September 2009
1
Magazine
FinanceAsia Magazine
FinanceAsia
December 2011/January 2012